English | 简体中文 | 繁體中文 | 한국어
 All Press Releases

Mitsubishi Chemical:Has developed new electrolyte for Tesla. The solvents and solute are supplied from Shida Shenghua
Sep 20, 2020 14:17 HKT
Mitsubishi Chemical:Has developed new electrolyte for Tesla. The solvents and solute are supplied from Shida Shenghua
Sep 20, 2020 13:13 HKT
The REL Token is Listed on CoinsBit and AzBit Cryptocurrency Exchanges. We, Release Project, Will Transform the Logistics of Agriculture and Fisheries Around the World
Sep 18, 2020 19:00 HKT
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
Sep 18, 2020 18:00 HKT
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
Sep 18, 2020 17:00 HKT
Tiger Brokers adds ASX to its Online Trading & Mobile App
Sep 18, 2020 13:30 HKT
NEC、横須賀市で全国初となるQRコードを用いた電子請求ソリューション「Haratte」の実証実験を開始
Sep 18, 2020 12:00 HKT
エーザイ、抗がん剤「ハラヴェン(R)」(エリブリン)リポソーム製剤の臨床第I相試験の最新データを欧州臨床腫瘍学会年次総会において発表
Sep 18, 2020 12:00 HKT
MITSUBISHI MOTORS Redesigns New ECLIPSE CROSS, Also Offered with Plug-in Hybrid Powertrain
Sep 18, 2020 11:09 HKT
Eisai Presents Latest Data of Phase I Clinical Trial on Liposomal Formulation of Anti-Cancer Agent Halaven (Eribulin) at ESMO Virtual Congress 2020
Sep 18, 2020 10:29 HKT
市场份额第一盈利能力强劲 快递龙头中通快递今日招股
Sep 18, 2020 10:23 HKT
市場份額第一盈利能力強勁 快遞龍頭中通快遞今日招股
Sep 18, 2020 10:22 HKT
AVIA Hosts the Satellite Industry Forum Focusing on Video in the Satellite World
Sep 18, 2020 10:00 HKT
富士通研究所、顔写真などによる他人へのなりすましを防止できる技術を開発
Sep 18, 2020 10:00 HKT
Fujitsu Develops Technology to Block Facial Authentication Fraud
Sep 18, 2020 09:20 HKT
TAITRA's Smart Manufacturing Webinar a Success, Captures Worldwide Buyer Attention
Sep 18, 2020 09:00 HKT
DoiT Signs Multi-Year, Strategic, Non-Binding 1.5 Billion Dollar Agreement with Google Cloud
Sep 17, 2020 21:00 HKT
Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
Sep 17, 2020 20:30 HKT
Dyadic宣布與江蘇恆瑞醫藥合作開發生物藥物
Sep 17, 2020 20:30 HKT
Dyadic宣布与江苏恒瑞医药合作开发生物药物
Sep 17, 2020 20:30 HKT
Next >>
 Releases By Language
All
English
Indonesian
Japanese
Korean
Thai
Trad. Chinese
Simp. Chinese
Vietnamese
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: